UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
March 29, 2016
Date of Report (Date of earliest event reported)
INVIVO THERAPEUTICS HOLDINGS CORP.
(Exact Name of Registrant as Specified in Charter)
Nevada |
|
001-37350 |
|
36-4528166 |
(State or Other |
|
(Commission File Number) |
|
(IRS Employer |
Jurisdiction of Incorporation) |
|
|
|
Identification No.) |
One Kendall Square, Suite B14402
Cambridge, Massachusetts 02139
(Address of Principal Executive Offices) (Zip Code)
(617) 863-5500
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On March 29, 2016, the Board of Directors of InVivo Therapeutics Holdings Corp. (the Company) approved an amendment to the first paragraph of Section 8, Article III of the Companys Amended and Restated Bylaws to permit directors to provide written consent by electronic mail or wireless transmission, effective immediately. The text of the amendment is filed herewith as Exhibit 3.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit |
|
|
Number |
|
Description |
|
|
|
3.1 |
|
Amendment to Amended and Restated Bylaws of InVivo Therapeutics Holdings Corp. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INVIVO THERAPEUTICS HOLDINGS CORP. | |
|
| |
Date: April 1, 2016 |
By: |
/s/ Tamara Joseph |
|
Name: |
Tamara Joseph |
|
Title: |
SVP, General Counsel & Chief Compliance Officer |
Exhibit Index
Exhibit |
|
|
Number |
|
Description |
|
|
|
3.1 |
|
Amendment to Amended and Restated Bylaws of InVivo Therapeutics Holdings Corp. |
Exhibit 3.1
Amendment to Amended and Restated Bylaws
Section 8. Action Without a Meeting; Telephone Conference Meeting. Unless otherwise restricted by the Articles of Incorporation, any action required or permitted to be taken at any meeting of the Board of Directors, or any committee designated by the Board of Directors, may be taken without a meeting if all members of the Board of Directors or committee, as the case may be, either originally or in counterparts, consent thereto in writing, which written consent may be given in the form of electronic mail or wireless transmission. Such consent shall have the same force and effect as a unanimous vote at a meeting, and may be stated as such in any document or instrument filed with the Secretary of State of Nevada.